Terrie Curran
2022
In 2022, Terrie Curran earned a total compensation of $5M as President and Chief Executive Officer at Phathom Pharmaceuticals, a 20% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $442,358 |
---|---|
Option Awards | $3,932,145 |
Salary | $650,000 |
Other | $15,375 |
Total | $5,039,878 |
Curran received $3.9M in option awards, accounting for 78% of the total pay in 2022.
Curran also received $442.4K in non-equity incentive plan, $650K in salary and $15.4K in other compensation.
Rankings
In 2022, Terrie Curran's compensation ranked 629th out of 5,676 executives tracked by ExecPay. In other words, Curran earned more than 88.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 629 | 89th |
Manufacturing | 271 | 91st |
Chemicals And Allied Products | 84 | 94th |
Drugs | 71 | 95th |
Pharmaceutical Preparations | 52 | 95th |
Curran's colleagues
We found two more compensation records of executives who worked with Terrie Curran at Phathom Pharmaceuticals in 2022.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020